CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


unfractionated HeparinWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)


Name (Synonyms) Correlation
drug942 FilmArray Pneumonia Wiki 1.00
drug2727 acetylsalicylic acid Wiki 1.00
drug2597 Unfractionated heparin nebulized Wiki 1.00
drug852 Enoxaparin Wiki 0.33

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D060085 Coinfection NIH 0.71

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial

Hypercoagulability has been demonstrated in COVID-19, leading to respiratory distress and increased mortality. This is adaptive clinical trial to compare effectiveness and safety of four therapeutic strategies in hospital mortality in patients with COVID-19: standard prophylaxis, therapeutic dose anticoagulation, inhaled UFH associated with standard prophylaxis and ASA associated with standard prophylaxis.

NCT04466670 COVID-19 Drug: unfractionated Heparin Drug: Unfractionated heparin nebulized Drug: acetylsalicylic acid Drug: Enoxaparin

Primary Outcomes

Description: Number of COVID-19 positive patients who are alive within 30 days of symptoms onset

Measure: Hospital discharge - alive / death

Time: 30 days

Secondary Outcomes

Description: Comparison of length of mechanical ventilation free days between each treatment arm

Measure: Length of mechanical ventilation free days

Time: 30 days

Description: Comparison of length of renal replacement therapy free days between each treatment arm

Measure: Length of renal replacement therapy free days

Time: 30 days

Description: Comparison of number of thrombosis events between each treatment arm.

Measure: Number of documented venous thromboembolism or arterial thrombosis

Time: 3 months


No related HPO nodes (Using clinical trials)